#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Endometrial cancer+12

Recruiting

Registered drugNo placebo

Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study on Linvoseltamab and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Have Not Yet Received Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Recruiting

Registered drugNo placebo

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Malignant melanoma

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Haematological malignancy

Recruiting

Registered drugNo placebo

Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tafasitamab

Contact Research Centre

Parkinson's disease

Recruiting

Registered drug

Study on the Safety and Effects of ACI-7104.056 in Patients with Early Parkinson's Disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Ioflupane (123I)

Contact Research Centre

Haemodynamic instability

Recruiting

Registered drugNo placebo

Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Dobutamine

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Endometrial cancer+38

Recruiting

InvestigationalNo placebo

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ds-3939A

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Art0380 Mesilate

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.